PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24426N0280Ioflupane - BRAND NAME or EQUAL — Jubilant Draximage Radiopharmacies, Inc

Jubilant Draximage Radiopharmacies, Inc holds $14.3M across 85 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C24425A0011. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jan 16, 2027 PoP end — agencies typically plan 12–18 months ahead.

244-Network Contract Office 4 (36C244)
Awarding office
Jubilant Draximage Radiopharmacies, Inc
Recipient
Jan 16, 2027
PoP end
$132K
Obligated
$132K
Potential
325412
NAICS
6550
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Jubilant Draximage Radiopharmacies, Inc — $90

Contract facts

NONE
Contract number36C24426N0280
Also listed as36C244-26-N-0280
Also listed as36C24425A0011-36C24426N0280
Agency244-Network Contract Office 4 (36C244)
Awarding office244-Network Contract Office 4 (36C244)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentJubilant Draximage Radiopharmacies, Inc
CAGE7YPV6
UEIZL79MXYVNDM1
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDV36C24425A0011
Place of performancePHILADELPHIA PA
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
PoP startJan 17, 2026
PoP end (current)Jan 16, 2027
Obligated$132K
Current value$132K
Potential value$132K

IOFLUPANE - BRAND NAME OR EQUAL is a federal NONE award for 244-Network Contract Office 4 (36C244) held by Jubilant Draximage Radiopharmacies, Inc. Estimated value $132K ($132K obligated). Current period of performance ends Jan 16, 2027. Last award drew 1 bidder. Place of performance: PHILADELPHIA PA.

Recompete timing

Public
Expiring in 148 days

Current PoP ends Jan 16, 2027 (148 days remaining). Agencies typically plan 12–18 months ahead — at 4.9 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Jubilant Draximage Radiopharmacies, Inc$14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($14.3M) · all agencies
Department of Veterans Affairs (VA)$14.1M · 99%Department of Defense (DOD)$157K · 1%
Open full company profile

Related awards

Same parent · incumbent
36C24826N0040
RADIOPHARMACEUTICALS
$885K
Sep 30, 2026
36C24826F0015
RADIOPHARMACEUTICALS OY
$752K
Sep 30, 2026
36C24526N0077
RADIOPHARMACEUTICALS
$600K
Sep 30, 2026
36C26326N0001
MINNEAPOLIS VAMC RADIOPHARMACEUTICAL AGENTS IDIQ
$492K
Sep 30, 2026
36C26226N0010
VA LOMA LINDA RADIOPHARMACEUTICALS OY1 DO
$469K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24426N0280?

36C24426N0280 (Ioflupane - BRAND NAME or EQUAL) is a 244-Network Contract Office 4 (36C244) award with a potential value of $132K, currently held by Jubilant Draximage Radiopharmacies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C244-26-N-0280?

36C244-26-N-0280 is the dashed form of PIID 36C24426N0280 (Ioflupane - BRAND NAME or EQUAL), held by Jubilant Draximage Radiopharmacies, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24426N0280?

244-Network Contract Office 4 (36C244) awarded 36C24426N0280 to Jubilant Draximage Radiopharmacies, Inc (potential $132K).

Who is the incumbent on 36C24426N0280?

Jubilant Draximage Radiopharmacies, Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Jan 16, 2027.

When does Jubilant Draximage Radiopharmacies, Inc’s 36C24426N0280 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 16, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24426N0280